AAPL 165.89 -1.41 (-0.84%)MSFT 103.94 -0.17 (-0.17%)FB 145.75 +5.44 (+3.88%)ZNGA 3.73 0 (+0.13%)NVDA 147.03 -3.17 (-2.11%)WBA 76.32 +0.25 (+0.34%)GOOG 1028.81 -16.22 (-1.55%)PIH 4.26 -0.74 (-14.80%)
AAPL 165.89 -1.41 (-0.84%)MSFT 103.94 -0.17 (-0.17%)FB 145.75 +5.44 (+3.88%)ZNGA 3.73 0 (+0.13%)NVDA 147.03 -3.17 (-2.11%)WBA 76.32 +0.25 (+0.34%)GOOG 1028.81 -16.22 (-1.55%)PIH 4.26 -0.74 (-14.80%)

Cash Flow ABT Quote Abbott Labo

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
NetIncome 4,423 1,400 477
Depreciation 0 0 0
DeferredIncomeT 0 0 0
StockBasedCompe 0 0 0
AccountsReceiva 0 0 0
InventoryCS 0 0 0
AccountsPayable 0 0 0
OtherWorkingCap 0 0 0
OtherNonCashIte 0 0 0
NetCashProvided 0 0 0
InvestmentsInPP 0 0 0
AcquisitionsNet 0 0 0
PurchasesOfInve 0 0 0
SalesMaturities 0 0 0
PurchasesOfInta 0 0 0
OtherInvestingA 0 0 0
NetCashUsedForI 0 0 0
DebtIssued 0 0 0
DebtRepayment 0 0 0
CommonStockIssu 0 0 0
CommonStockRepu 0 0 0
DividendPaid 0 0 0
OtherFinancingA 0 0 0
NetCashProvided 0 0 0
NetChangeInCash 0 0 0
CashAtBeginning 0 0 0
CashAtEndOfPeri 0 0 0
Abbott Laboratories income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Abbott Laboratories FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.